ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P ASX 200
7,035.30
(
0.0%
)
S&P ASX All Technology
2,463.00
(
0.0%
)
Brent Oil
82.645
(
1.44%
)
US Dollar vs AUD
1.51057
(
0.56%
)
Bitcoin
37,806.42
(
-0.08%
)
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aterian Inc (ATER)

  7. Aterian Inc (ATER) News

ATER Aterian Inc

0.3151
-0.015 (-4.54%)
After Hours
Last Updated: 08:58:29
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Aterian Inc ATER NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.015 -4.54% 0.3151 08:58:29
Open Price Low Price High Price Close Price Previous Close
0.3361 0.3168 0.345799 0.3151 0.3301
more quote information »

Recent News

Date Time Source Heading
18/11/202308:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202309:43EDGAR2Form 144 - Report of proposed sale of securities
14/11/202300:30GLOBESquatty Potty Re-Launches In Walmart Stores Nationwide
10/11/202301:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/11/202309:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:34EDGAR2Form 8-K - Current report
09/11/202308:15GLOBEAterian Reports Third Quarter 2023 Results
28/10/202308:30GLOBEAterian Sets Date for Third Quarter 2023 Earnings..
25/10/202308:06EDGAR2Form 8-K - Current report
25/10/202307:50GLOBEAterian Receives Extension To Regain Compliance With Nasdaq..
19/9/202307:16EDGAR2Form 8-K - Current report
16/9/202309:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202311:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202311:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202311:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202311:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202311:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202311:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/9/202321:00GLOBEAterian Announces Participation in the H.C. Wainwright 25th..
14/8/202323:15EDGAR2Form 8-K - Current report
10/8/202306:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202306:40EDGAR2Form 8-K - Current report
09/8/202306:15GLOBEAterian Reports Second Quarter 2023 Results
01/8/202322:45GLOBEAterian Sets Date for Second Quarter 2023 Earnings..
01/8/202306:20GLOBEAterian, Inc. Reports Inducement Grant Under Nasdaq Listing..
27/7/202323:48EDGAR2Form 8-K - Current report
27/7/202323:00GLOBEAterian Announces Management Change & Second Quarter 2023..
15/7/202307:00EDGAR2Form 8-K - Current report
01/7/202307:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/5/202306:15GLOBEAterian Reports First Quarter 2023 Results
28/4/202307:00GLOBEAterian Sets Date for First Quarter 2023 Earnings..
19/4/202321:30GLOBEAterian Announces Updated First Quarter 2023 Net Revenue and..
03/4/202322:00GLOBEAterian Named 233rd Fastest Growing Company in the Americas..
01/4/202307:20GLOBEAterian, Inc. Reports Inducement Grants Under Nasdaq Listing..
10/3/202308:15GLOBEAterian Reports Fourth Quarter & Full Year 2022 Results
04/3/202308:01GLOBEAterian, Inc. Reports Inducement Grants Under Nasdaq Listing..
27/2/202323:00GLOBEAterian Sets Date for Fourth Quarter & Full Year 2022..
22/2/202300:30GLOBEAterian Announces Further Expansion in Europe
06/2/202323:00GLOBEAterian Announces Management Promotions and Changes
17/1/202323:00GLOBEAterian Announces Preliminary Fourth Quarter & Full Year..
02/12/202208:30GLOBEAterian Announces Strong Cyber Monday Sales

Your Recent History

NASDAQ
ATER
Aterian

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com